To identify the product ideas for portfolio expansion in critical care for the US pre-filled syringe market.
Client’s requirement
A pharma company from Europe partnered with Excelra to study the US market for pre-filled syringes by specifically looking at areas such as US FDA regulations and patent expiry products.
Our approach
Excelra’s experts curated key data points from multiple sources including five major regulatory agencies from the US, Europe, India, Japan, and Russia. This curated dataset further helped our experts with data points covering formulation, dosage, and indications.
This dataset further went through an analytical approach to rank and prioritize based on critical care indication and unmet medical needs. Leveraging our expertise in data curation and cheminformatics, Excelra ensured high-quality structured datasets that could be readily applied for scientific data management.
Excelra’s expertise helped the client with the top five product ideas in critical care!
For reference, explore how we supported strategic growth in portfolio augmentation for a potential biologic drug and delivered insights through data-driven competitive landscape analysis.
